News

The agency has also accepted the company’s investigational new drug (IND) application to begin a Phase II trial of cobiprostone to prevent oral mucositis in patients suffering with

Saizen is a recombinant human Growth Hormone (r-hGH) registered in the US to treat growth hormone deficiency (GHD) in children and adults. As part of the deal, Aeterna

The company’s latest report* states that this increase, which will occur across nine major markets (9MM), namely the US, France, Germany, Italy, Spain, the UK, Japan, China, and

Under the deal, a Phase I/II trial will be conducted to evaluate the combination of Plexxikon’s investigational CSF-1R inhibitor, PLX3397, and Merck’s anti-PD-1 therapy, Keytruda (pembrolizumab), which provides

Enrollment activities at all 28 sites are now closed and no new patients will be accepted into the study. Randomization is expected to be completed in approximately 4

The Appeals court also dissolved the injunction preventing Actavis from further distribution of its generic version of Pulmicort Respules that was granted on March 12, 2015. "We are

Founded in 2005 by Myrtle Potter, Myrtle Potter & Company specializes in devising novel strategies to maximize the value of prescription drug brands and portfolios. "We have a

The acquisition of Hyperion occurred through a merger under Section 251(h) of the General Corporation Law of the State of Delaware following Horizon’s successful tender for 86% of

The studies, led by Moffitt researchers Heather Jim, PhD, Diane Portman, MD, Howard McLeod, PharmD, and Gillian Bell, PharmD will examine a number of genetic variants as predictors